How Clinical Supply Teams can Respond to the Growth in Investigator Initiated Trials

Summer is nearly here for most of us, but the pharmaceutical industry is going back to school.

Over the past several years there has been a surge of activity in clinical trials that are funded by industry but sponsored and conducted by academic investigators. According to information from the U.S. National Institutes of Health, the number of Investigator Initiated Trials almost tripled between 2011 and 2014.

Along with this growing body of academic research comes increased pressure for the clinical supply chain. Industry supply professionals must respond to the wave of unique needs presented by these investigators while ensuring drug arrives at clinical sites with the same efficiency as it does for traditional registration trials.

The Webinar “How Clinical Supply Teams can Respond to the Growth in Investigator Initiated Trials” will help attendees understand the surprising ways these studies impact the supply function. Clinical supply teams working in this evolving facet of the industry face a whole host of new questions. For instance, how much guidance do the investigators and site teams require? Are there ways to manage supplies more effectively so both types of trials benefit equally? How will the team respond if the investigator adds clinical sites in new regions or countries? What are the best ways to control costs when prices for comparator medications are escalating rapidly?

The Webinar will draw from direct experience providing clinical supply strategies for Investigator Initiated Trials and an extensive analysis of the study protocols. As the world’s largest company dedicated to clinical supplies, Fisher Clinical Services is uniquely placed to understand this trend and forecast its implications for clinical teams.

Join us to learn more and be ready the next time you’re called on to support this vital and dynamic field of clinical research.

KEY LEARNING OBJECTIVES

• Understand how investigator initiated trials are changing the R&D landscape for clinical supply teams
• Develop supply strategies for integrating the demand of these trials with traditional registration studies
• Become a more effective supply chain leader who can advise clinical management on effective solutions for investigator initiated trials

Speaker

Helen Underwood, Director of Strategic Customer Relationships, Fisher Clinical Services

Joining Fisher Clinical Services in July 2010, Helen Underwood serves as a Director of Strategic Customer Relationships. A former client, Helen brought with her a valued perspective into how Fisher Clinical Services manages client relationships and has a particular interest in innovation.

With over 20 years in the pharma industry, the majority of this time in the R&D function of a global Top 10 company, Helen is a proven pharmacist and has been a practitioner in clinical trial supply. She also deals in project management to support new drug development in worldwide clinical trials, with a focus on risk and supply chain management to reduce timelines and costs.

Another Scottish export on the team, she enjoys the outdoors and celebrated as her fellow Scots made the 2014 Commonwealth Games in Glasgow an event to surpass London 2012.

Message Presenter